US$ 23.36
bpc-157 mechanism tendon healing angiogenesis Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating and the NO-System Gastric pentadecapeptide body protection compound
Description
These calculations use 15-30mcg/kg as the reference range

People with active cancer should consult their oncologist before using any immunomodulatory peptide, including Ta1 (despite its use in cancer immunotherapy in some countries) and BPC-157 (due to angiogenesis promotion)

If a vial has already been reconstituted, concentration, date mixed, solvent volume, discard date, and storage history should be written down

USA 104, 37993804 (2007)